Status:
UNKNOWN
Cognitive Function After Stem Cell Transplantation
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Fatigue
Cognitive Impairment
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The trial will evaluate the effects of an exercise program on the physical and cognitive performance of patients with hematological neoplastic diseases after high dose chemotherapy with stem cell supp...
Detailed Description
Patients (n = 60) will be randomized to an exercise or a control group. The randomization will be stratified for allogeneic or autologous blood stem cell transplantation. Patients in the exercise grou...
Eligibility Criteria
Inclusion
- Age 18 - 70
- Hematological neoplastic disease
- Treatment with high-dose chemotherapy with peripheral blood stem cell transplantation in the previous 3 years
- Karnofsky-Index \> 80%
- Ability to understand German
Exclusion
- Cardiorespiratory, metabolic, inflammatory or osteoarticular diseases which can be aggravated by exercise
- Psychosis
- Organic brain damage
- Dementia
- PBSCT in the previous 6 weeks
- Pathological stress test at admission
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00884338
Start Date
May 1 2009
End Date
September 1 2011
Last Update
December 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 12200